124. Microbiological Outcomes With Plazomicin (PLZ) Versus Meropenem (MEM) in Patients With Complicated Urinary Tract Infections (cUTI), Including Acute Pyelonephritis (AP) in the EPIC Study

BACKGROUND: PLZ is a next-generation aminoglycoside (AG) that is structurally protected from common AG-modifying enzymes (AMEs) in Enterobacteriaceae and with in vitro activity against multidrug-resistant Enterobacteriaceae, including ESBL-producing, AG-resistant, and carbapenem-resistant isolates....

詳細記述

保存先:
書誌詳細
出版年:Open Forum Infect Dis
主要な著者: Keepers, Tiffany R, Cebrik, Deborah S, Cloutier, Daniel J, Komirenko, Allison, Connolly, Lynn, Krause, Kevin
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2018
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6253087/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy209.014
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料